ANTI-CD19 IMMUNOTOXINS

Details for Australian Patent Application No. 2002258665 (hide)

Owner PROGENICS PHARMACEUTICALS, INC.

Inventors OLSON, William, C.; MADDON, Paul, J.; MA, Dangshe

Pub. Number AU-A-2002258665

PCT Pub. Number WO2002/080987

Priority 60/282,587 09.04.01 US

Filing date 29 March 2002

Wipo publication date 21 October 2002

International Classifications

A61K 051/10 Preparations containing radioactive substances for use in therapy or testing

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 016/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2002258665

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258666-Radiopaque alloy stent

2002258664-Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof